Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma.

Cancer medicine - 1 Sept 2021

Cheng Fajuan, Zheng Bin, Wang Jianwei, Zhao Guiting, Yao Zhongshun, Niu Zhihong, He Wei

Abstract excerpt

Histone deacetylases (HDAC) family is vital for tumorigenesis and tumor progression. However, the exact role of the HDAC family in clear cell renal cell carcinoma (ccRCC) remains unclear. Based on The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC), and The Human Protein Atlas (HPA) database, we investigated and validated the expression profile, clinical significance and prognostic value...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinogenesis
Share to Carcinoma, Renal Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Datasets as Topic

Share to DNA Copy Number Variations

Share to Histone Deacetylases

Share to Kaplan-Meier Estimate

Share to Kidney Neoplasms

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 34308568
DOI: 10.1002/cam4.4156
PMCID: PMC8446567

Genes

HDAC10
HDAC11
HDAC8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma.PMID 34308568Read ↗

Identification of HDAC10 as a candidate oncogene in clear cell renal carcinoma that facilitates tumor proliferation and metastasis.Semantic proximity Read ↗

Novel Molecular Subtypes and Related Score Based on Histone Acetylation Modification in Renal Clear Cell CarcinomaSemantic proximity Read ↗

Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cellsSemantic proximity Read ↗

Patient Stratification of Clear Cell Renal Cell Carcinoma Using the Global Transcription Factor Activity Landscape Derived From RNA-Seq DataSemantic proximity Read ↗

The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinomaSemantic proximity Read ↗

Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology.Semantic proximity Read ↗

Comprehensive Analysis of the Expression and Prognosis for <i>PSMBs</i> in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Succinylation Regulators Promote Clear Cell Renal Cell Carcinoma by Immune Regulation and RNA N6-Methyladenosine MethylationSemantic proximity Read ↗

Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinomaSemantic proximity Read ↗

Deciphering potential molecular mechanisms in clear cell renal cell carcinoma based on the ubiquitin‐conjugating enzyme E2 related genes: Identifying UBE2C correlates to infiltration of regulatory T cellsSemantic proximity Read ↗

Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.